Kim So-Yun, Kang Da Hyun, Ju Hyekyeong, Oh Dong Kyu, Lee Su Yeon, Park Mi Hyeon, Lim Chae-Man, Lee Song I
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National School of Medicine, Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon, 35015, Republic of Korea.
Department of Pulmonary and Critical Care Medicine, Dongkang Medical Center, Ulsan, Republic of Korea.
Sci Rep. 2025 Apr 30;15(1):15249. doi: 10.1038/s41598-025-98584-x.
Approximately half of the patients with sepsis require intensive care unit (ICU) management and their mortality rate remains high. The concept of withholding and withdrawal life-sustaining treatment (WWLST) issue was introduced to limit the suffering of critically ill patients. However, little is known about the characteristics and outcomes of WWLST in patients with sepsis. We conducted a nationwide cohort study of adult patients with sepsis prospectively collected from the Korean Sepsis Alliance Database of 20 tertiary referral or university-affiliated hospitals in South Korea between September 2019 and December 2021. Patients were classified according to WWLST issues and characteristics, and their prognoses were compared. Among the 11,981 patients with sepsis included in the study, 4430 (37.0%) had WWLST issues. The WWLST group was older, frailer, and had higher Sequential Organ Failure Assessment (SOFA) scores than the no-WWLST group. The WWLST group had more underlying diseases, including solid tumors (45.2% vs. 30.6%, p < 0.001) and hematologic malignancies (8.0% vs. 5.2%, p < 0.001), than the no-WWLST group. Regarding patient outcomes and interventions in the ICU, the WWLST group used vasopressors (35.4% vs. 32.8%, p = 0.003) more frequently; invasive mechanical ventilation (62.9% vs. 41.9%, p < 0.001) and continuous renal replacement therapy (40.8% vs. 17.6%, p < 0.001) were applied more frequently in the WWLST group than in the no-WWLST group. Logistic regression analysis revealed the factors associated with WWLST group to be old age, low body mass index, higher Charlson comorbidity index, clinical frailty scale, SOFA score, underlying diseases such as solid tumors and hematologic malignancies, invasive mechanical ventilation, and continuous renal replacement therapy. We predicted that the WWLST group would have a fewer ICU admissions and less invasive treatment. However, the admission rate was equivalent, and the percentage of invasive treatment, length of ICU stays, and mortality rate were higher and longer in the WWLST group. In patients with sepsis who have factors related to WWLST, appropriate communication with the patient and their family about WWLST can improve the quality of life and quality of death.
约半数脓毒症患者需要重症监护病房(ICU)管理,且其死亡率仍然很高。维持生命治疗的 withhold 和 withdrawal(WWLST)问题的概念被引入,以限制重症患者的痛苦。然而,对于脓毒症患者中 WWLST 的特征和结局知之甚少。我们对 2019 年 9 月至 2021 年 12 月期间从韩国 20 家三级转诊或大学附属医院的韩国脓毒症联盟数据库中前瞻性收集的成年脓毒症患者进行了一项全国性队列研究。根据 WWLST 问题和特征对患者进行分类,并比较他们的预后。在纳入研究的 11981 例脓毒症患者中,4430 例(37.0%)存在 WWLST 问题。与无 WWLST 组相比,WWLST 组患者年龄更大、身体更虚弱,序贯器官衰竭评估(SOFA)评分更高。与无 WWLST 组相比,WWLST 组有更多的基础疾病,包括实体瘤(45.2% 对 30.6%,p < 0.001)和血液系统恶性肿瘤(8.0% 对 5.2%,p < 0.001)。关于 ICU 中的患者结局和干预措施,WWLST 组更频繁地使用血管升压药(35.4% 对 32.8%,p = 0.003);与无 WWLST 组相比,WWLST 组更频繁地应用有创机械通气(62.9% 对 41.9%,p < 0.001)和持续肾脏替代治疗(40.8% 对 17.6%,p < 0.001)。逻辑回归分析显示,与 WWLST 组相关的因素包括老年、低体重指数、更高的 Charlson 合并症指数、临床衰弱量表、SOFA 评分、实体瘤和血液系统恶性肿瘤等基础疾病、有创机械通气以及持续肾脏替代治疗。我们预测 WWLST 组的 ICU 入院次数会更少且侵入性治疗更少。然而,入院率相当,且 WWLST 组的侵入性治疗百分比、ICU 住院时间和死亡率更高、更长。在有与 WWLST 相关因素的脓毒症患者中,就 WWLST 与患者及其家属进行适当沟通可改善生活质量和死亡质量。